U.S. flag

An official website of the United States government

NM_000454.5(SOD1):c.304G>A (p.Asp102Asn) AND Amyotrophic lateral sclerosis type 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 8, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003518824.2

Allele description [Variation Report for NM_000454.5(SOD1):c.304G>A (p.Asp102Asn)]

NM_000454.5(SOD1):c.304G>A (p.Asp102Asn)

Gene:
SOD1:superoxide dismutase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.11
Genomic location:
Preferred name:
NM_000454.5(SOD1):c.304G>A (p.Asp102Asn)
HGVS:
  • NC_000021.9:g.31667322G>A
  • NG_008689.1:g.12701G>A
  • NM_000454.5:c.304G>AMANE SELECT
  • NP_000445.1:p.Asp102Asn
  • NP_000445.1:p.Asp102Asn
  • LRG_652t1:c.304G>A
  • LRG_652:g.12701G>A
  • LRG_652p1:p.Asp102Asn
  • NC_000021.8:g.33039635G>A
  • NM_000454.4:c.304G>A
Protein change:
D102N
Molecular consequence:
  • NM_000454.5:c.304G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Amyotrophic lateral sclerosis type 1 (ALS1)
Synonyms:
AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL
Identifiers:
MONDO: MONDO:0007103; MedGen: C1862939; Orphanet: 803; OMIM: 105400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004297373Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 8, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient.

Jones CT, Shaw PJ, Chari G, Brock DJ.

Mol Cell Probes. 1994 Aug;8(4):329-30.

PubMed [citation]
PMID:
7870076

Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.

Hou L, Jiao B, Xiao T, Zhou L, Zhou Z, Du J, Yan X, Wang J, Tang B, Shen L.

Sci Rep. 2016 Sep 8;6:32478. doi: 10.1038/srep32478.

PubMed [citation]
PMID:
27604643
PMCID:
PMC5015023
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004297373.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 102 of the SOD1 protein (p.Asp102Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 7870076, 27604643, 34518333). In at least one individual the variant was observed to be de novo. This variant is also known as Asp101Asn. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOD1 protein function with a positive predictive value of 95%. This variant disrupts the p.Asp102 amino acid residue in SOD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14759637, 15235802; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024